ARTICLE | Company News

Agensys, Genentech deal

July 26, 2004 7:00 AM UTC

DNA acquired an exclusive worldwide license to develop and commercialize therapeutics and associated diagnostics using two cancer targets from Agensys. DNA also gained rights to certain monoclonal antibodies developed by Agensys. Agensys retains rights to vaccines and certain diagnostic applications. ...